Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90

FDA recall notice · announced October 3, 2018 · Hetero Labs, Ltd. - Unit Iii

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90

Reason for recall

Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.

Notes

Distribution: Indiana and Louisiana
Lot/code information: Lot #: E181370, Exp. 5/2020
Quantity: 5,424 bottles
Status: Terminated
Products in this recall event:
- Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90 (D-1211-2018)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.